S. 4494

119 S4494 IS: American Cures Act
 U.S. Senate
 2026-05-12
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 II  119th CONGRESS  2d Session  S. 4494  IN THE SENATE OF THE UNITED STATES   May 12, 2026   Mr. Durbin  (for himself,  Mr. Blumenthal ,  Ms. Duckworth , and  Mr. Van Hollen ) introduced the following bill; which was read twice and referred to the  Committee on Appropriations    A BILL
To prioritize funding for an expanded and sustained national investment in biomedical research.
1.
Short title
This Act may be cited as the   American Cures Act  .
2.
Appropriations for Innovation
(a)
In general
There are hereby authorized to be appropriated, and appropriated, out of any monies in the Treasury not otherwise appropriated, the following:
(1)
National Institutes of Health
For the National Institutes of Health at the Department of Health and Human Services—
(A)
for fiscal year 2027, $52,467,132,000;
(B)
for fiscal year 2028, $56,507,101,164;
(C)
for fiscal year 2029, $60,858,147,954;
(D)
for fiscal year 2030, $65,544,225,346;
(E)
for fiscal year 2031, $70,591,130,698;
(F)
for fiscal year 2032, $76,026,647,762;
(G)
for fiscal year 2033, $81,880,699,640;
(H)
for fiscal year 2034, $88,185,513,512;
(I)
for fiscal year 2035, $94,975,798,052;
(J)
for fiscal year 2036, $102,288,934,502; and
(K)
for fiscal year 2037 and each fiscal year thereafter, the amount appropriated under this paragraph for the previous fiscal year, increased by the percentage increase (if any), during the previous fiscal year, in the Consumer Price Index for all urban consumers published by the Bureau of Labor Statistics.
(2)
Centers for Disease Control and Prevention
For the Centers for Disease Control and Prevention at the Department of Health and Human Services—
(A)
for fiscal year 2027,$ 9,911,621,307;
(B)
for fiscal year 2028, $10,674,816,148;
(C)
for fiscal year 2029, $11,496,776,991;
(D)
for fiscal year 2030, $12,382,028,819;
(E)
for fiscal year 2031, $13,335,445,038;
(F)
for fiscal year 2032, $14,362,274,306;
(G)
for fiscal year 2033, $15,468,169,428;
(H)
for fiscal year 2034, $16,659,218,474;
(I)
for fiscal year 2035, $17,941,978,296;
(J)
for fiscal year 2036, $19,323,510,625; and
(K)
for fiscal year 2037 and each fiscal year thereafter, the amount appropriated under this paragraph for the previous fiscal year, increased by the percentage increase (if any), during the previous fiscal year, in the Consumer Price Index for all urban consumers published by the Bureau of Labor Statistics.
(3)
Research, development, test, and evaluation program of the Department of Defense health program
For the research, development, test, and evaluation program of the Department of Defense health program—
(A)
for fiscal year 2027, $2,939,358,093;
(B)
 for fiscal year 2028, $3,165,688,666;
(C)
for fiscal year 2029, $3,409,451,694;
(D)
for fiscal year 2030, $3,671,979,474;
(E)
for fiscal year 2031, $3,954,721,894;
(F)
for fiscal year 2032, $4,259,235,480;
(G)
for fiscal year 2033, $4,587,196,612;
(H)
for fiscal year 2034, $4,940,412,751;
(I)
for fiscal year 2035, $5,320,824,534;
(J)
for fiscal year 2036, $5,730,508,023; and
(K)
for fiscal year 2037 and each fiscal year thereafter, the amount appropriated under this paragraph for the previous fiscal year, increased by the percentage increase (if any), during the previous fiscal year, in the Consumer Price Index for all urban consumers published by the Bureau of Labor Statistics.
(4)
Medical and prosthetics research program of the Department of Veterans Affairs
For the medical and prosthetics research program of the Department of Veterans Affairs—
(A)
for fiscal year 2027, $1,071,765,000;
(B)
for fiscal year 2028, $1,096,132,905;
(C)
for fiscal year 2029, $1,180,535,138;
(D)
for fiscal year 2030, $1,271,436,344;
(E)
for fiscal year 2031, $1,369,336,942;
(F)
for fiscal year 2032, $1,474,775,887;
(G)
for fiscal year 2033, $1,588,333,630;
(H)
for fiscal year 2034, $1,710,636,320;
(I)
for fiscal year 2035, $1,842,355,321;
(J)
for fiscal year 2036, $1,984,218,681; and
(K)
for fiscal year 2037 and each fiscal year thereafter, the amount appropriated under this paragraph for the previous fiscal year, increased by the percentage increase (if any), during the previous fiscal year, in the Consumer Price Index for all urban consumers published by the Bureau of Labor Statistics.
(b)
Availability
Amounts appropriated under subsection (a) shall remain available until expended.
(c)
Definitions
In this section:
(1)
Centers for Disease Control and Prevention
The term  Centers for Disease Control and Prevention  means the appropriations accounts that support the various institutes, offices, and centers that make up the Centers for Disease Control and Prevention.
(2)
Research, development, test, and evaluation program of the Department of Defense health program
The term  research, development, test, and evaluation program of the Department of Defense health program  means the appropriations accounts that support the various institutes, offices, and centers that make up the research, development, test, and evaluation program of the Department of Defense health program.
(3)
Medical and prosthetics research program of the Department of Veterans Affairs
The term  medical and prosthetics research program of the Department of Veterans Affairs  means the appropriations accounts that support the various institutes, offices, and centers that make up the medical and prosthetics research program of the Department of Veterans Affairs.
(4)
National Institutes of Health
The term  National Institutes of Health  means the appropriations accounts that support the various institutes, offices, and centers that make up the National Institutes of Health.
(d)
Exemption of certain appropriations from sequestration
(1)
In general
Section 255(g)(1)(A) of the Balanced Budget and Emergency Deficit Control Act ( 2 U.S.C. 905(g)(1)(A) ) is amended by inserting after  Advances to the Unemployment Trust Fund and Other Funds (16–0327–0–1–600).  the following:
Appropriations under the  American Cures Act .
 .
(2)
Applicability
The amendment made by this section shall apply to any sequestration order issued under the Balanced Budget and Emergency Deficit Control Act of 1985 ( 2 U.S.C. 900 et seq. ) on or after the date of enactment of this Act.
(e)
Budgetary effects
(1)
Statutory paygo scorecards
The budgetary effects of this section shall not be entered on either PAYGO scorecard maintained pursuant to section 4(d) of the Statutory Pay-As-You-Go Act of 2010 ( 2 U.S.C. 933(d) ).
(2)
Senate paygo scorecards
The budgetary effects of this section shall not be entered on any PAYGO scorecard maintained for purposes of section 4106 of H. Con. Res. 71 (115th Congress).